3-(4,4,5,5-Tetraethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98%, 10g

1-Benzyl-4-methylpiperidin-3-one, 95.0%, 10g

3-azabicyclo[3.1.0]hexane-2-carboxylic acid hydrochloride, 95.0%, 250mg

dimetilsulfóxido, min 99,5%, para síntesis, 25 l, envase de plástico.

Imidazo[1,5-a]pyridine-8-carboxylic acid, 95.0%, 1g

Fmoc-N-PEG24-acid, 1g

3-Ethylbicyclo[3.2.0]hept-3-en-6-one, 95%, 5g

Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate, 95.0%, 100mg

2,9-Diaminoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone, 98%, 1g

4'-Nitro-4-dimethylaminoazobenzene>98.0%(T)5g

Ethyl 2-chloro-5-hydroxybenzoate, 95.0%, 1g

2-Bromo-3-iodotoluene, 98.0%, 250mg

4-[(5-chloropyridin-2-yl)oxy]benzoic acid, 95%, 250mg